Bernie Sanders Urges Discussion on Ozempic Manufacturing Costs with Novo Nordisk CEO

Thursday, 28 March 2024, 20:18

Bernie Sanders is seeking a meeting with Novo Nordisk's CEO after a study revealed that Ozempic can be manufactured for just $5 a month. The weight-loss drug's high monthly price of around $1,000 has raised concerns, leading Sanders to push for transparency and cost reduction in the pharmaceutical industry.
https://store.livarava.com/ff4c020d-ed72-11ee-8907-87cc5c87fb08.jpg
Bernie Sanders Urges Discussion on Ozempic Manufacturing Costs with Novo Nordisk CEO

Bernie Sanders Takes on Pharmaceutical Industry

Senator Bernie Sanders is advocating for a meeting with Novo Nordisk CEO, Lars Fruergaard Jørgensen, to address the manufacturing costs of the weight-loss drug, Ozempic. The drug, which costs approximately $1,000 per month, has come under scrutiny after a study revealed it can be manufactured for as low as $5 per month.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe